Duke University School of Medicine, Durham, NC, USA.
Department of Anesthesiology, Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA.
Can J Anaesth. 2024 Nov;71(11):1518-1524. doi: 10.1007/s12630-024-02786-2. Epub 2024 Jun 17.
It is unclear if postoperative pain experience and opioid consumption differ in patients undergoing primary vs repeat Cesarean delivery (CD) as prior studies have yielded conflicting results and none used the same patients as their own controls. We sought to compare opioid consumption and pain scores in patients undergoing both a primary and a first repeat CD, using the same patients as their own controls.
We conducted a single-centre historical cohort study of patients who underwent both a primary and a first repeat CD under neuraxial anesthesia between 1 January 2016 and 30 November 2022. The same standardized multimodal analgesic regimen was used for all patients. The primary outcome was opioid consumption in oral morphine equivalents (OME) at 48 hr after surgery. Secondary outcomes included area under the curve for pain scores at 24 and 48 hr, and opioid consumption at 24 hr.
We included 409 patients. In unadjusted analysis, there were no significant differences between primary and repeat CD in median [interquartile range] opioid consumption at 48 hr (45 [15-89] mg vs 45 [15-83] mg OME) or in any of the secondary outcomes. In the multivariable model adjusting for age, body mass index, anxiety, depression, priority, surgery duration, gestational age, receipt of postoperative ketorolac, and neuraxial type, repeat CD was still not associated with increased opioid consumption compared with primary CD (adjusted rate ratio, 1.20; 95% confidence interval, 0.95 to 1.51).
In this retrospective study, we found no differences in postoperative opioid consumption or reported pain scores in patients who underwent both a primary and a first repeat CD.
先前的研究结果相互矛盾,且均未使用同一患者作为自身对照,因此,尚不清楚初次剖宫产(CD)与首次重复剖宫产患者的术后疼痛体验和阿片类药物消耗量是否存在差异。我们旨在比较同一患者作为自身对照的初次 CD 和首次重复 CD 患者的阿片类药物消耗量和疼痛评分。
我们对 2016 年 1 月 1 日至 2022 年 11 月 30 日期间在椎管内麻醉下接受初次和首次重复 CD 的患者进行了单中心回顾性队列研究。所有患者均使用相同的标准化多模式镇痛方案。主要结局是术后 48 小时口服吗啡等效物(OME)的阿片类药物消耗量。次要结局包括 24 和 48 小时疼痛评分的曲线下面积,以及 24 小时的阿片类药物消耗量。
我们纳入了 409 名患者。在未调整分析中,初次 CD 和重复 CD 患者在术后 48 小时的中位数(四分位距)阿片类药物消耗量(45 [15-89]mg 比 45 [15-83]mg OME)或任何次要结局均无显著差异。在调整年龄、体重指数、焦虑、抑郁、手术优先级、手术时间、孕龄、术后给予酮咯酸和椎管内类型等因素的多变量模型中,与初次 CD 相比,重复 CD 仍与阿片类药物消耗量增加无关(调整后的比率比,1.20;95%置信区间,0.95 至 1.51)。
在这项回顾性研究中,我们发现初次 CD 和首次重复 CD 患者的术后阿片类药物消耗量或报告的疼痛评分无差异。